HK1131789A1 - Improved antimicrobial peptides - Google Patents

Improved antimicrobial peptides

Info

Publication number
HK1131789A1
HK1131789A1 HK09109702.1A HK09109702A HK1131789A1 HK 1131789 A1 HK1131789 A1 HK 1131789A1 HK 09109702 A HK09109702 A HK 09109702A HK 1131789 A1 HK1131789 A1 HK 1131789A1
Authority
HK
Hong Kong
Prior art keywords
antimicrobial peptides
improved antimicrobial
improved
peptides
antimicrobial
Prior art date
Application number
HK09109702.1A
Other languages
English (en)
Inventor
Artur Schmidtchen
Martin Malmsten
Original Assignee
Pergamum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pergamum Ab filed Critical Pergamum Ab
Publication of HK1131789A1 publication Critical patent/HK1131789A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK09109702.1A 2006-05-16 2009-10-21 Improved antimicrobial peptides HK1131789A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80064406P 2006-05-16 2006-05-16
SE0601088 2006-05-16
PCT/SE2007/000477 WO2007133153A1 (fr) 2006-05-16 2007-05-15 Peptides antimicrobiens améliorés

Publications (1)

Publication Number Publication Date
HK1131789A1 true HK1131789A1 (en) 2010-02-05

Family

ID=38694156

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109702.1A HK1131789A1 (en) 2006-05-16 2009-10-21 Improved antimicrobial peptides

Country Status (9)

Country Link
US (1) US8227406B2 (fr)
EP (1) EP2021364B8 (fr)
JP (1) JP5330230B2 (fr)
KR (1) KR101487719B1 (fr)
AU (1) AU2007250558B2 (fr)
CA (1) CA2651990C (fr)
HK (1) HK1131789A1 (fr)
MX (1) MX2008014415A (fr)
WO (1) WO2007133153A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4511173B2 (ja) 2001-08-24 2010-07-28 マイジェニックス インコーポレイテッド 抗菌性および抗炎症性ペプチド
CN101720237A (zh) * 2007-06-25 2010-06-02 利波佩普蒂德有限公司 新型医用产品
WO2009109156A2 (fr) * 2008-03-04 2009-09-11 Ustav Organicke Chemie A Bioch Nouveaux peptides antimicrobiens et leur application
CZ301822B6 (cs) * 2008-03-04 2010-06-30 Ústav organické chemie a biochemie Akademie ved Ceské republiky, v.v.i. Peptid, zpusob jeho prípravy a jeho použití
CZ301774B6 (cs) * 2008-06-10 2010-06-16 Ústav organické chemie a biochemie, Akademie ved CR v. v. i. Syntetické peptidy a jejich použití
GB0821721D0 (en) * 2008-11-27 2008-12-31 Hansa Medical Ab Antimicrobial therapy
JP2011178674A (ja) * 2010-02-26 2011-09-15 Tokai Univ 抗菌剤
EP2547700A1 (fr) * 2010-03-17 2013-01-23 Universität Regensburg Peptides ou anticorps se liant à une protéine à activité inhibitrice du mélanome
WO2012033450A1 (fr) * 2010-09-07 2012-03-15 Dermagen Ab Nouveaux peptides antimicrobiens
US9187541B2 (en) 2011-04-27 2015-11-17 The Regents Of The University Of California Anti-microbial peptides and methods of use thereof
US9987316B2 (en) * 2012-09-14 2018-06-05 Case Western Reserve University Probiotic controlling fungi and uses thereof
KR20150134417A (ko) * 2013-03-29 2015-12-01 메리맥 파마슈티컬즈, 인크. 연골-결합 융합 단백질
KR101599587B1 (ko) * 2013-10-11 2016-03-14 건국대학교 산학협력단 다제내성균에 대한 항균, 항진균, 항염증 활성을 보이는 프로태티아마이신 항생펩타이드 유도체 및 그 용도
US20190204312A1 (en) * 2016-09-16 2019-07-04 Technische Universität München Magnetic particle-binding peptides
CN110279844A (zh) * 2019-01-31 2019-09-27 浙江星杭泰乐生物医药有限公司 人工合成抗菌肽在制备抑菌消炎祛痘化妆品或外用药物制剂中的应用及抑菌消炎祛痘组合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
US5912230A (en) * 1991-11-01 1999-06-15 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
AU1086595A (en) * 1993-11-08 1995-05-29 Demeter Biotechnologies, Ltd. Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
JP3459314B2 (ja) 1994-08-31 2003-10-20 社団法人農林水産技術情報協会 新規ペプチド、抗菌剤、新規ペプチド遺伝子、新規な組み換え体ｄｎａ及び新規ペプチドの製造法
GB9504761D0 (en) 1995-03-09 1995-04-26 Unilever Plc Amphiphilic peptide and analogs thereof
US5834430A (en) 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
CA2192782C (fr) 1995-12-15 2008-10-14 Nobuyuki Takechi Production de microsphere
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO2001031019A2 (fr) 1999-10-29 2001-05-03 Chiron Spa Peptides antigeniques de neisseria
WO2000001427A1 (fr) 1998-07-02 2000-01-13 Stichting Skeletal Tissue Engineering Group Amsterdam Ciment a base d'os, contenant des peptides antimicrobiens
US20030083244A1 (en) 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
JP4511173B2 (ja) * 2001-08-24 2010-07-28 マイジェニックス インコーポレイテッド 抗菌性および抗炎症性ペプチド
DE10160170A1 (de) * 2001-12-07 2003-07-17 Ipf Pharmaceuticals Gmbh Neue antimikrobielle Bolisinpeptide
EP1581556A2 (fr) 2002-08-15 2005-10-05 Leukotech A/S Peptides bactericides, anti-apoptose, pro-inflammatoires et anti-inflammatoires de la proteine de liaison heparine (hbp)
JP4154218B2 (ja) 2002-11-27 2008-09-24 寛紀 高麗 新規抗菌性ポリペプチドとその利用
WO2004058809A2 (fr) 2002-12-26 2004-07-15 Affinium Pharmaceuticals, Inc. Nouveaux polypeptides bacteriens essentiels
SE0301431D0 (sv) 2003-05-19 2003-05-19 Dermagen Novel antimicrobial peptides
JP2008500007A (ja) 2003-05-30 2008-01-10 インターツェル・アクチェンゲゼルシャフト 腸球菌抗原
ES2332516T3 (es) 2003-06-30 2010-02-08 Kyong-Ja Jung Procedimiento y aparato para almacenar y transferir contenedores.
JP2008514586A (ja) 2004-09-27 2008-05-08 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド 新規な抗菌剤
EP1824976A4 (fr) * 2004-11-12 2008-07-09 Univ British Columbia Peptides antimicrobiens
SE0402807D0 (sv) * 2004-11-17 2004-11-17 Dermagen Ab Novel antimicrobial peptides

Also Published As

Publication number Publication date
EP2021364A1 (fr) 2009-02-11
CA2651990C (fr) 2014-12-23
AU2007250558A1 (en) 2007-11-22
US20100159006A1 (en) 2010-06-24
EP2021364A4 (fr) 2009-11-25
KR101487719B1 (ko) 2015-01-29
EP2021364B8 (fr) 2014-05-21
US8227406B2 (en) 2012-07-24
EP2021364B1 (fr) 2014-04-09
KR20090027213A (ko) 2009-03-16
MX2008014415A (es) 2009-01-29
WO2007133153A1 (fr) 2007-11-22
AU2007250558B2 (en) 2012-10-25
JP2009537515A (ja) 2009-10-29
JP5330230B2 (ja) 2013-10-30
WO2007133153A8 (fr) 2009-07-23
CA2651990A1 (fr) 2007-11-22

Similar Documents

Publication Publication Date Title
IL199835A0 (en) Novel antimicrobial peptides
EP2061886A4 (fr) Peptides antimicrobiens cationiques de petite taille
HK1131789A1 (en) Improved antimicrobial peptides
HRP20130109T1 (en) Caspofungin formulations
IL197413A0 (en) Compositions comprising selectively targeted antimicrobial peptides
EP2004674A4 (fr) Proteine antimicrobienne
IL240686A0 (en) Antimicrobial cyclic peptides
PL1849352T3 (pl) Kombajn
ZA200806486B (en) Antimicrobial materials
ZA200810738B (en) Polypeptide
EP2017283A4 (fr) Peptide
EP2010561A4 (fr) Peptides antimicrobiens
HK1139421A1 (en) Antibacterial peptides
EP2046816A4 (fr) Variante de protéine g de streptocoque marquée par de la cystéine
EP2123666A4 (fr) Peptide
EP2017285A4 (fr) Peptides linéaires antimicrobiens
DK2021364T3 (da) Forbedrede antimikrobielle peptider
SG10201403126RA (en) Cyclic antimicrobial peptides
GB0618748D0 (en) Peptide
GB0605774D0 (en) Peptide
GB0703945D0 (en) Peptide
IL197675A0 (en) Peptides
EP2097439A4 (fr) Nouveaux peptides
EP2091959A4 (fr) Composition peptidique améliorée
GB0609920D0 (en) Peptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180515